Analyst Doug Mavrinac launched coverage of the shipowner with a $20 per share target price, well above its $14 per share IPO level.
In a note to clients Mavrinac explained the positive view was influenced by a strengthening market, Iranian production adding volumes to the market, improving tonne mile demand and higher fleet efficiency.
Jefferies, an underwriter on its IPO, believes Gener8 will turn a $47.08m
